-
Tenneco Clean
524.00 437.85(%) -
Finolex Cables
1,375.00 1,375.00(%) -
Godrej Consumer
908.00 908.00(%) -
Max Healthcare
1,002.00 903.50(%) -
HDFC Bank
722.00 722.00(%) -
TD Power Systems
1,529.00 1,529.00(%) -
SBI
1,085.00 1,234.80(%) -
Grasim Inds
3,270.00 2,504.35(%) -
Hindustan Copper
569.85 759.20(%) -
Hindalco Inds.
1,088.25 1,179.35(%) -
TCS
2,301.10 1,976.00(%) -
Multi Comm. Exc.
2,987.85 3,479.80(%) -
Hind.Aeronautics
5,054.40 5,054.40(%) -
Fortis Health.
879.30 767.30(%) -
Apar Inds.
18,432.40 18,432.40(%) -
Axis Bank
1,216.80 1,041.30(%) -
Billionbrains
197.95 227.00(%) -
Marksans Pharma
319.90 319.90(%) -
Ardee Industries
73.60 73.60(%) -
LG Electronics
1,584.00 1,736.40(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Kwality Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 68403.0
- ISIN : INE552U01010
-
Today’s Low
3,240.10 -
Today’s High
3,374.80
-
Open
3,300.00 -
Perv Close
3,310.50 -
52W Low
1,561.00 -
52W High
3,450.00
Key Indicators
-
P/E(TTM)
42.18
-
Mar.Cap (₹Cr.)
3,438.46
-
Div & Yield %
0.00
-
Book Value(₹)
320.52
-
Debt-Equity Ratio
0.10
-
AGM Date
12-Aug-2026
-
EPS
78.68
-
P/E Ratio
42.18
Financials Ratios
-
Debt-Equity Ratio
0.45
-
Mar.Cap (₹Cr.)
3,438.46
-
RONW (%)
13.66
-
ROCE (%)
15.86
Score Board
-
Equity (₹ in Cr.)
10.38
-
BV (₹)
320.50
-
Sales( ₹ in Cr.)
503.06
-
NP (in Cr.)
67.43
-
NP Var(%)
69.0
-
Div%
0.0
-
CPS (₹)
84.10
-
EPS (₹)
65.00
-
Traded Value (₹ in Lakhs)
3,443.60
-
52 Week High
3,450.00
-
52 Week Low
1,561.00
-
Price BSE
3319.0
-
Price NSE
3,314.00
-
Market Capital( in Cr.)
3,443.60
-
P/C Ratio
39.50
-
P/E Ratio
51.10
-
Price Vs.BV
65.00
-
10-Aug-2026( 02:43)
Results - Announcements - Kwali... - Kwality Pharmaceuticals Ltd sh...
-
08-Aug-2026( 09:53)
Corporate News - Kwali... - Kwality Pharmaceuticals Limite...
-
24-Jul-2026( 11:10)
Corporate News - Kwali... - Kwality Pharmaceuticals has ac...
-
19-May-2026( 12:59)
Results - Announcements - Kwali... - Net profit of Kwality Pharmace...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 503.06 | 370.20 | 307.17 | 250.99 | 456.13 | 261.50 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 503.06 | 370.20 | 307.17 | 250.99 | 456.13 | 261.50 |
| Other Income | 2.86 | 1.92 | 1.83 | 2.94 | 3.51 | 1.59 |
| Stock Adjustments | -0.28 | -1.17 | 1.48 | 3.20 | 2.51 | -0.09 |
| Total Income | 505.64 | 370.95 | 310.48 | 257.13 | 462.15 | 263.00 |
| EXPENDITURE : | ||||||
| Raw Materials | 258.16 | 181.31 | 154.66 | 113.27 | 203.11 | 165.50 |
| Power and Fuel Cost | 26.69 | 23.37 | 17.22 | 12.96 | 11.06 | 6.11 |
| Employee Cost | 51.10 | 41.24 | 30.43 | 28.10 | 18.74 | 14.48 |
| Other Manufacturing Expenses | 2.96 | 3.32 | 6.75 | 4.98 | 4.57 | 3.78 |
| Selling and Administration Expenses | 44.42 | 37.31 | 30.74 | 32.57 | 48.71 | 41.12 |
| Miscellaneous Expenses | 2.05 | 2.03 | 9.32 | 17.97 | 0.72 | 1.16 |
| Employee Benefit Expenses | 51.10 | 41.24 | 30.43 | 28.10 | 18.74 | 14.48 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 385.39 | 288.58 | 249.12 | 209.85 | 286.91 | 232.14 |
| Operating Profit | 120.26 | 82.37 | 61.37 | 47.29 | 175.24 | 30.86 |
| Interest | 10.97 | 9.88 | 10.39 | 6.61 | 2.92 | 2.62 |
| Gross Profit | 109.29 | 72.49 | 50.98 | 40.68 | 172.32 | 28.24 |
| Depreciation | 19.79 | 18.26 | 19.51 | 14.92 | 10.64 | 6.44 |
| Profit Before Tax | 89.50 | 54.23 | 31.47 | 25.76 | 161.68 | 21.80 |
| Current Tax | 23.03 | 15.93 | 7.92 | 6.16 | 41.35 | 6.22 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.89 | -1.59 | -0.44 | 0.14 | 0.27 | 0.16 |
| Reported Net Profit | 67.35 | 39.89 | 23.98 | 19.47 | 120.05 | 15.42 |
| Extraordinary Items | -0.09 | 0.04 | -5.31 | -12.24 | 0.00 | -0.01 |
| Adjusted Net Profit | 67.44 | 39.85 | 29.29 | 31.71 | 120.05 | 15.43 |
| Adjustment below Net Profit | 0.18 | 0.01 | -0.06 | 0.00 | 0.08 | 0.00 |
| P & L Balance brought forward | 246.20 | 206.30 | 182.38 | 162.91 | 42.78 | 27.37 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 313.73 | 246.20 | 206.30 | 182.38 | 162.91 | 42.78 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 64.90 | 38.44 | 23.11 | 18.76 | 115.69 | 14.86 |
| Earnings Per Share(Adj)-Unit Curr | 64.90 | 38.44 | 23.11 | 18.76 | 115.69 | 14.86 |
| Book Value | 320.51 | 255.43 | 216.98 | 193.93 | 175.17 | 59.47 |
| Book Value(Adj)-Unit Curr | 320.51 | 255.43 | 216.98 | 193.93 | 175.17 | 59.47 |
